 |
|
New finding in studying dopamine transporter
June 07, 2005New Haven, Conn.-Confirming findings in a previous study, Yale researchers observed an altered availability of the dopamine transporter in healthy persons with a genetic variation linked to substance abuse and attention deficit hyperactivity disorder (ADHD).
"Healthy people who carry a particular variant of the dopamine transporter gene, the nine repeat allele, have significantly higher levels of dopamine transporter in the brain," said the lead author, Christopher van Dyck, M.D., associate professor of psychiatry and neurobiology and director of the Alzheimer's Disease Research Unit and the Cognitive Disorders Clinic in the Department of Psychiatry.
The new study included 96 healthy European Americans-54 men and 42 women-who underwent a clinical examination to exclude any neurological or psychiatric disease, alcohol abuse or substance abuse. The levels of dopamine transporter availability were measured using SPECT imaging, and the dopamine transporter genotypes were determined by co-author Joel Gelernter, M.D.
"We are not yet sure if the effects of the variant on transporter levels in our healthy subjects can be generalized to neuropsychiatric disorders," van Dyck said. "If they can be, our results may be relevant for substance abuse, tobacco smoking, and ADHD. "The results suggest that the mechanism of association of this gene with several disorders could be altered levels of central dopamine transporter protein, influencing concentrations of extracellular dopamine.
This study replicated and expanded on a preliminary report by Leslie Jacobsen, M.D., and colleagues at Yale, although other studies of the effects of this variation on the availability of the dopamine transporter have yielded contradictory results.
In addition to Jacobsen and Gelernter, co-authors included Robert Malison, M.D., John Seibyl, M.D., Julie Staley, Marc Laruelle, M.D., Ronald Baldwin, and Robert Innis, M.D. The study was supported by grants and funds from the American Federation for Aging Research; Rose and Philip Hoffer; the Department of Veterans Affairs; the National Institute of Mental Health, and the National Institute on Drug Abuse.
Yale University
"We are not yet sure if the effects of the variant on transporter levels in our healthy subjects can be generalized to neuropsychiatric disorders," van Dyck said. "If they can be, our results may be relevant for substance abuse, tobacco smoking, and ADHD. "The results suggest that the mechanism of association of this gene with several disorders could be altered levels of central dopamine transporter protein, influencing concentrations of extracellular dopamine.
This study replicated and expanded on a preliminary report by Leslie Jacobsen, M.D., and colleagues at Yale, although other studies of the effects of this variation on the availability of the dopamine transporter have yielded contradictory results.
In addition to Jacobsen and Gelernter, co-authors included Robert Malison, M.D., John Seibyl, M.D., Julie Staley, Marc Laruelle, M.D., Ronald Baldwin, and Robert Innis, M.D. The study was supported by grants and funds from the American Federation for Aging Research; Rose and Philip Hoffer; the Department of Veterans Affairs; the National Institute of Mental Health, and the National Institute on Drug Abuse.
Yale University
Dopamine Transporter Current Events and Dopamine Transporter News RSSStudy reveals specific gene in adolescent men with delinquent peers
Birds of a feather flock together, according to the old adage, and adolescent males who possess a certain type of variation in a specific gene are more likely to flock to delinquent peers.
Protein found that regulates gene critical to dopamine-releasing brain cells
Researchers have identified a protein they say appears to be a primary player in maintaining normal functioning of an important class of neurons - those brain cells that produce, excrete and then reabsorb dopamine neurotransmitters.
N.Y. Research Team Discovers How Antidepressants and Cocaine Interact with Brain Cell Targets
In a first, scientists from Weill Cornell Medical College and Columbia University Medical Center have described the specifics of how brain cells process antidepressant drugs, cocaine and amphetamines. These novel findings could prove useful in the development of more targeted medication therapies for a host of psychiatric diseases, most notably in the area of addiction.
Are Anxiety Disorders All in the Mind?
Using single-photon emission computed tomography (SPECT), researchers in The Netherlands were able to detect biochemical differences in the brains of individuals with generalized social anxiety disorder (also known as social phobia), providing evidence of a long-suspected biological cause for the dysfunction.
A reduced arousal threshold in Drosophila mutants prevents them from staying asleep
Most short-sleeping mutant phenotypes in Drosophila (a genus of small flies) are characterized by an inability to stay asleep, most likely because of a reduced arousal threshold, according to a study published in the April 1 issue of the journal SLEEP.
Cocaine's effects on brain metabolism may contribute to abuse
Many studies on cocaine addiction - and attempts to block its addictiveness - have focused on dopamine transporters, proteins that reabsorb the brain's "reward" chemical once its signal is sent.
The dopamine transporter gene influences alcohol withdrawal seizures
The physiological component of alcoholism is defined by tolerance and/or withdrawal: the more severe the dependency on alcohol, the more severe the clinical complications, such as greater intensity and/or complications of alcohol withdrawal.
Insulin signaling and amphetamines
Abuse of psychostimulants such as amphetamine remains a serious public health concern. Amphetamines mediate their behavioral effects by stimulating dopaminergic signaling throughout reward circuits of the brain.
Neural stem cells reduce Parkinson's symptoms in monkeys
Primates with severe Parkinson's disease were able to walk, move, and eat better, and had diminished tremors after being injected with human neural stem cells.
High Dopamine Transporter Levels Not Correlated with ADHD
Results from a brain-imaging study conducted at the U.S. Department of Energy's Brookhaven National Laboratory in collaboration with Mount Sinai School of Medicine in New York indicate that levels of a brain protein proposed as a diagnostic marker for attention-deficit hyperactivity disorder (ADHD) are not positively correlated with the disease.
More Dopamine Transporter Current Events and Dopamine Transporter News Articles
 | Dopamine Receptors And Transporters: Function, Imaging And Clinical Implication (Neurological Disease and Therapy) , Georgetown Univ., Washington D.C. Text presents updated information on the basic and clinical advances in the field. Focuses on the clinical application of treating dopamine-linked diseases such as Parkinson's disease, Tourette's syndrome, and attention hyperactivity disorder. Previous edition:... |
| Distribution of the 3' VNTR Polymorphism in the Human Dopamine Transporter Gene in World Populations.: An article from: Human Biology by R.j. Mitchell, S. Howlett, L. Earl, N.g. White, J. Mccomb, M.s. Schanfield, I. Briceno, S.s. Papiha, L. Osipova, G. Livshits, W.r. Leonard, M.h. Crawford This digital document is an article from Human Biology, published by Wayne State University Press on April 1, 2000. The length of the article is 4403 words. The page length shown above is based on a typical 300-word page. The article is delivered in HTML format and is available in your Amazon.com Digital Locker immediately after purchase. You can view it with any web browser.Citation... | |
| Dopamine transporter ligand binding domains analyzed through photoaffinity labeling.(Collegiate Communications--Graduate) : An article from: Proceedings of the North Dakota Academy of Science by M. Laura Parnas, Jon D. Gaffaney, Amy H. Newman, Mu-Fa Zou, John R. Lever, Aloke K. Dutta, Rohit Kolhatkar, Roxanne A. Vaughan This digital document is an article from Proceedings of the North Dakota Academy of Science, published by Thomson Gale on April 1, 2005. The length of the article is 426 words. The page length shown above is based on a typical 300-word page. The article is delivered in HTML format and is available in your Amazon.com Digital Locker immediately after purchase. You can view it with any web... | |
| Syntaxin 1A regulates dopamine transporter phosphorylation and activity.(Collegiate Communications--Graduate): An article from: Proceedings of the North Dakota Academy of Science by Mark A. Cervinski, Roxanne Vaughan This digital document is an article from Proceedings of the North Dakota Academy of Science, published by Thomson Gale on April 1, 2005. The length of the article is 572 words. The page length shown above is based on a typical 300-word page. The article is delivered in HTML format and is available in your Amazon.com Digital Locker immediately after purchase. You can view it with any web... | |
| Localizing site of protein kinase C stimulated phosphorylation on dopamine transporter. (Collegiate Communications--Undergraduate).(Brief Article): An ... of the North Dakota Academy of Science by Benchaporn Pananusorn, Roxanne Vaughan This digital document is an article from Proceedings of the North Dakota Academy of Science, published by North Dakota Academy of Science on April 1, 2000. The length of the article is 745 words. The page length shown above is based on a typical 300-word page. The article is delivered in HTML format and is available in your Amazon.com Digital Locker immediately after purchase. You can view it... | |
| Genetic polymorphism of the 3' VNTR region of the human dopaminergic function gene DAT1 (human dopamine transporter gene) in the Mongolian population. ... repeats): An article from: Human Biology by M. Nakatome, K. Honda, Z. Tun, Y. Kato, S. Harihara, K. Omoto, S. Misawa, T. Gerelsaikhan, S. Nyamkhishig, B. Dashnyam, J. Batsuuri, C. Wakasugi This digital document is an article from Human Biology, published by Wayne State University Press on August 1, 1996. The length of the article is 2093 words. The page length shown above is based on a typical 300-word page. The article is delivered in HTML format and is available in your Amazon.com Digital Locker immediately after purchase. You can view it with any web browser.From the author: KEY... | |
| Purification of a photoaffinity labeled proteolytic fragment from cloned human dopamine transporter. (Professional Communications).(Brief Article): An ... of the North Dakota Academy of Science by Margaret Jean Lowe, Roxanne A. Vaughan This digital document is an article from Proceedings of the North Dakota Academy of Science, published by North Dakota Academy of Science on April 1, 2001. The length of the article is 561 words. The page length shown above is based on a typical 300-word page. The article is delivered in HTML format and is available in your Amazon.com Digital Locker immediately after purchase. You can view it... | |
| Characterization of photoaffinity labeled proteolytic fragments from cloned human dopamine transporter. (Professional Communications).(Brief Article): ... of the North Dakota Academy of Science by Margaret Jean Lowe, Roxanne A. Vaughan This digital document is an article from Proceedings of the North Dakota Academy of Science, published by North Dakota Academy of Science on April 1, 2000. The length of the article is 594 words. The page length shown above is based on a typical 300-word page. The article is delivered in HTML format and is available in your Amazon.com Digital Locker immediately after purchase. You can view it... | |
 | Dopamine Transporters: Chemistry, Biology, and Pharmacology (Wiley Series in Drug Discovery and Development) Understanding the dopamine transporter can lead to new therapies for neurological disorders This book consolidates current information on the dopamine transporter (DAT) in relationto medicinal chemistry and synthesis, biology and pathology, and pharmacology. Because of DAT's role in diseases such as Parkinson's, schizophrenia, attention deficit hyperactivity disorder (ADHD), Tourette... |
| Dopamine Receptors and Transporters: Pharmacology, Structure, and Function by Niznik Provides comprehensive coverage of each dopamine receptor transporter system, including up-to-date reviews of the molecular biology, gene evolution, pharmacology, topology, signal transduction properties, anatomical distribution and regulation. The book explains the genetic characterization of the dopamine receptor/transporter gene family and its relationship to the etiology and maintenance of... |
| © 2008 BrightSurf.com |